1-7 of 7
Paola Bonetti
Close
Sort by
Journal Articles

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

Michela Boi, Andrea Rinaldi, Ivo Kwee, Paola Bonetti, Maria Todaro, Fabrizio Tabbò, Roberto Piva, Paola M. V. Rancoita, András Matolcsy, Botond Timar, Thomas Tousseyn, Socorro Maria Rodríguez-Pinilla, Miguel A. Piris, Sílvia Beà, Elias Campo, Govind Bhagat, Steven H. Swerdlow, Andreas Rosenwald, Maurilio Ponzoni, Ken H. Young, Pier Paolo Piccaluga, Reinhard Dummer, Stefano Pileri, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni
Journal: Blood
Blood (2013) 122 (15): 2683–2693.
https://doi.org/10.1182/blood-2013-04-497933
Published: 2013
Includes: Supplemental data
Journal Articles

Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma

Paola Bonetti, Monica Testoni, Marta Scandurra, Maurilio Ponzoni, Roberto Piva, Afua A. Mensah, Andrea Rinaldi, Ivo Kwee, Maria Grazia Tibiletti, Javeed Iqbal, Timothy C. Greiner, Wing-Chung Chan, Gianluca Gaidano, Miguel A. Piris, Franco Cavalli, Emanuele Zucca, Giorgio Inghirami, Francesco Bertoni
Journal: Blood
Blood (2013) 122 (13): 2233–2241.
https://doi.org/10.1182/blood-2013-01-475772
Published: 2013
Includes: Supplemental data
Journal Articles

The Brd-Inhibitor OTX015 Shows Pre-Clinical Activity in Anaplastic Large T-Cell Lymphoma (ALCL)

Michela Boi, Paola Bonetti, PhD, Maurilio Ponzoni, Maria Grazia Tibiletti, Anastasios Stathis, MD, Esteban Cvitkovic, MD, Giorgio Inghirami, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2012) 120 (21): 4872.
https://doi.org/10.1182/blood.V120.21.4872.4872
Published: 2012
Journal Articles

The Brd-Inhibitor OTX015 Is Active in Pre-Clinical Models of Mature B-Cell Lymphoid Tumors

Paola Bonetti, PhD, Michela Boi, Maurilio Ponzoni, Maria Grazia Tibiletti, Anastasios Stahis, Giorgio Inghirami, Kay Noel, PhD, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2012) 120 (21): 1657.
https://doi.org/10.1182/blood.V120.21.1657.1657
Published: 2012
Journal Articles

BLIMP1 Is Commonly Inactivated In Anaplastic Large T-Cell Lymphomas (ALCL)

Michela Boi, Andrea Rinaldi, Roberto Piva, Paola MV Rancoita, PhD, Paola Bonetti, Andras Matolcsy, MD, Thomas Tousseyn, MD PhD, Socorro Maria Rodríguez-Pinilla, Miguel Piris, MD, Sílvia Beà, Elias Campo, MD, Govind Bhagat, M.D., Steven H. Swerdlow, MD, Andreas Rosenwald, MD, Maurilio Ponzoni, MD, Ken H. Young, MD, Pier Paolo Piccaluga, Stefano Pileri, MD, Antonino Neri, Enzo Medico, Emanuele Zucca, MD, Ivo Kwee, Giorgio Inghirami, Francesco Bertoni, MD
Journal: Blood
Blood (2011) 118 (21): 2634.
https://doi.org/10.1182/blood.V118.21.2634.2634
Published: 2011
Journal Articles

Recurrent 11q24.3 Gain Contributes to the Pathogenesis of Diffuse Large B Cell Lymphoma (DLBCL) by Deregulating ETS1 and FLI1

Paola Bonetti, Monica Testoni, Marta Scandurra, Maurilio Ponzoni, MD, Roberto Piva, Afua Adjeiwaa Mensah, Maria Grazia Tibiletti, Ivo Kwee, Timothy C. Greiner, MD, Wing C. Chan, MD, Gianluca Gaidano, Miguel Piris, MD, Emanuele Zucca, MD, Francesco Bertoni, MD
Journal: Blood
Blood (2011) 118 (21): 1386.
https://doi.org/10.1182/blood.V118.21.1386.1386
Published: 2011
Journal Articles

The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway

Paola Martinelli, Paola Bonetti, Cristina Sironi, Giancarlo Pruneri, Caterina Fumagalli, Paola Rafaniello Raviele, Sara Volorio, Stefano Pileri, Roberto Chiarle, Fiona Kate Elizabeth McDuff, Betsabeh Khoramian Tusi, Suzanne D. Turner, Giorgio Inghirami, Pier Giuseppe Pelicci, Emanuela Colombo
Journal: Blood
Blood (2011) 117 (24): 6617–6626.
https://doi.org/10.1182/blood-2010-08-301135
Published: 2011
Includes: Supplemental data